In addition to observing effects on non-tumor breast cells, Syed et al. [117] showed that delphinidin treatment caused growth inhibition of breast cancer cells that express HGF, suggesting that this compound could prevent HGF-mediated activation of signaling pathways implicated in breast cancer. Here, HGF is linked to breast cancer.